News & Publications

Press Releases

Atavistik Bio Raises Additional $40 Million to Advance Precision Allosteric Small Molecule Therapeutics >> READ MORE
Atavistik Bio Appoints Bryan Stuart as Chief Executive Officer >> READ MORE
Atavistik Bio Announces Publication in Science by Co-Founder Jared Rutter Describing Foundational Technology for its Atavistik Metabolite-Protein Screening (AMPS) Platform >> READ MORE
Atavistik Bio Announces Collaboration with Plex Research to Enrich the Informatics Capabilities of its AMPS Platform and Accelerate the Discovery of Novel Small Molecule Therapeutics >> READ MORE
Atavistik Bio Announces Formation of Scientific Advisory Board >> READ MORE
Atavistik Bio Announces $60 Million Series A Financing to Advance Genetically-Validated Targets in Metabolic Diseases and Cancer >> READ MORE


Examples of Multicomponent reactions (MCR) show impact towards the discovery of clinical compounds and expansion of topologically rich molecular chemotypes as described by Atavistik Bio in ACSMedicinal Chemistry Letters
>> Read Article
Atavistik Bio’s foundational technology to systematically identify and characterize the complex network of protein-metabolite interactions and their regulatory significance described in recent Science publication.
>> Read Article


The Search to Unlock Protein-Metabolite Interactions
An interview with Jared Rutter, Ph.D. and Kevin Hicks, Ph.D. About Atavistik Bio’s Foundational Technology and the Inspiration
>> Read More